Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

New research shows that BMP inhibitors are able to reverse the main untreatable symptom of multiple myeloma, a type of bone marrow cancer.

Pre clinical study able to regrow bone in myeloma model © David Gregory & Debbie Marshall CC BY 4.0

The research, led by Dr Sarah Gooding, is an equal collaboration between the groups of Professor Hal Drakesmith at the MRC Human Immunology Unit (RDM) and the group of Professor Claire Edwards at the Nuffield Department of Surgical Sciences and NDORMS.

Read more (MRC Weatherall Institute of Molecular Medicine webiste)